food and drug administration fda news

Schizophrenia, Food and Drug Administration

In a Victory for the Free Market, FDA Approves New Schizophrenia Drug

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical company.

Time on MSN · 13h

FDA Approves the First New Schizophrenia Drug in Decades

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely different way from existing medications for schizophrenia, which is building excitement and enthusiasm among doctors and patients alike.

92.7 WMAY · 12h

FDA approves first new drug for schizophrenia in more than 30 years

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers

U.S. News & World Report · 4h

US FDA Approves GE HealthCare's Diagnostic Drug for Heart Disease

The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery disease, the company said on Friday. Flyrcado, which is a radioactive diagnostic drug for positron emission tomography (PET) myocardial perfusion imaging (MPI),

ANSWERS Pet Food recalled over salmonella, listeria concerns

YAHOO!News · 1d

FDA issues recall notices for two brands of pet food over salmonella and listeria contamination

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them

USA TODAY on MSN · 1d

ANSWERS Pet Food recalled over salmonella, listeria concerns: What pet owners need to know

ANSWERS Pet Food is voluntarily recalling several of its products due to potential salmonella and listeria exposure, according to the FDA.

wtvr · 2d

Dog foods recalled after testing positive for salmonella and listeria

A brand of dog food has been recalled after testing positive for salmonella and listeria, creating a risk for humans who have handled the products.

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 1d

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Business Insider · 1d

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.

MarketWatch · 1d

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

Hosted on MSN3m

US FDA Clears First One-Year Continuous Glucose Monitoring Sensor; Can Help Manage Diabetes Better

The US Food and Drug Administration has cleared Senseonics’ Eversense 365, the latest implantable continuous glucose ...

Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD

Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary ...

Dog food pulled from shelves nationwide: FDA

The U.S. Food and Drug Administration reports a pet food company is voluntarily withdrawing some of their beef and chicken ...

ksby47m

FDA approves first new medication to treat schizophrenia in more than 30 years

People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...

5hon MSN

New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...

Business Wire3h

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

FDA approves new schizophrenia drug

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.

13h

FDA Approves New Schizophrenia Drug in 70-Year First

The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.

STAT6h

The FDA is ‘making sandwiches,’ ‘breakfast salad’ in DC, and what keeps us from choking on food

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results